Chronic Myeloid Leukemia (CML)


Recent Programs

The Changing CML Treatment Landscape

Dr. Jessica Altman discusses the changing treatment landscape in CML and treatments available for newly diagnosed patients and treatment resistant patients.

Published:

What Challenges Do CML Patients Face in Staying on a Treatment Schedule?

Missing treatments--even just a few doses--can be detrimental to people with CML. So what can cause a patient to miss a dose? Greg Stephens, executive director of the National CML Society, explains.

Published:

Ongoing Research Offers Hope for CML Patients

Dr. Jan Cerny explains how this very early animal research is advancing the search for a cure to CML.

Published:

Featured Blog
CLL and Lymphoma Drug Approvals: Kudos to the FDA

By Andrew Schorr


Page last updated on April 17, 2014